Mark Harper
Main Page: Mark Harper (Conservative - Forest of Dean)Department Debates - View all Mark Harper's debates with the Cabinet Office
(3 years, 9 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
The Prime Minister
I am delighted to see the hon. Gentleman back on fighting form. Having enjoyed lively on-screen debates with him in the past, it is good to see him back in shape. He is right to draw attention to the long-term consequences of the disease, and we will do everything we can to alleviate suffering and to continue to invest in support for those who need it.
Mr Mark Harper (Forest of Dean) (Con)
First, I thank the Prime Minister for the measures to get our children back to school on 8 March, which is very welcome—it is something we have called for, and I think he should be congratulated on that—and also for the speed of the vaccine roll-out. Could I just press him a little on the thoughts behind vaccinating groups 1 to 9, which is everyone over 50 and those aged 16 to 64 with a health condition that makes them vulnerable to covid? Those groups account for 99% of deaths and around 80% of hospitalisations, so for what reason, once they have been vaccinated and protected from covid by the end of April at the latest, is there any need for restrictions to continue?
The Prime Minister
My right hon. Friend makes an excellent point. The difficulty is that, of course, there will be at least a significant minority who either have not taken up the vaccine in those vulnerable groups for the reasons that the House has been discussing or who, having had the vaccine, are not given sufficient protection. We believe that the protection is very substantial, but there will be a large minority who will not have sufficient protection. The risk is that letting the brakes off could see the disease surge up in such a way as again to rip through a large number or rip through those groups in a way that I do not think anybody in this country would want. I am afraid it is pure mathematics; there is still a substantial body of risk. We also need to wait and see exactly what the effects of the vaccine are. There is some promising data, but I think what the country would want at this stage is caution and certainty and irreversibility, and that is what we aim to provide.